NANOGALAXY
Live / Registered — Registered (as of 25 Mar 2025)
What this means for you
Registered since 25 Mar 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 25 Mar 2031: the §8 declaration of use).
Record
- Serial number
- 97259976
- Registration number
- 7739559
- Mark type
- Word mark
- Filed
- 09 Feb 2022
- Published for opposition
- 14 Feb 2023
- Registered
- 25 Mar 2025
- Next maintenance filing
- §8 declaration of use, due by 25 Mar 2031 (grace period to 25 Sept 2031)
- Attorney of record
- Anne E. Naffziger
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, polymer drug delivery agents in the form of compounds in the nature of therapeutic proteins and nucleic acids that facilitate delivery of a wide variety of pharmaceuticals
Owner
- GenEdit Inc., South San Francisco, CA, US
- GenEdit Inc., South San Francisco, CA, US
- GenEdit Inc., South San Francisco, CA, US
Prosecution history
- 25 Mar 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Mar 2025 — REGISTERED-PRINCIPAL REGISTER
- 01 Mar 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Mar 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Feb 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Dec 2024 — USE AMENDMENT FILED
- 14 Feb 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Dec 2024 — TEAS STATEMENT OF USE RECEIVED
- 24 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Sept 2024 — SOU EXTENSION 3 GRANTED
- 24 Sept 2024 — SOU EXTENSION 3 FILED
- 24 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 28 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Mar 2024 — SOU EXTENSION 2 GRANTED
- 27 Mar 2024 — SOU EXTENSION 2 FILED